180 related articles for article (PubMed ID: 25868465)
1. Benefits and barriers to the public health pharmacy: a qualitative exploration of providers' and commissioners' perceptions of the Healthy Living Pharmacy framework.
Firth H; Todd A; Bambra C
Perspect Public Health; 2015 Sep; 135(5):251-6. PubMed ID: 25868465
[TBL] [Abstract][Full Text] [Related]
2. England's Healthy Living Pharmacy (HLP) initiative: Facilitating the engagement of pharmacy support staff in public health.
Donovan GR; Paudyal V
Res Social Adm Pharm; 2016; 12(2):281-92. PubMed ID: 26104681
[TBL] [Abstract][Full Text] [Related]
3. From community pharmacy to healthy living pharmacy: positive early experiences from Portsmouth, England.
Brown D; Portlock J; Rutter P; Nazar Z
Res Social Adm Pharm; 2014; 10(1):72-87. PubMed ID: 23731701
[TBL] [Abstract][Full Text] [Related]
4. Benefits and tensions in delivering public health in community pharmacies - a qualitative study of healthy living pharmacy staff champions.
Cooper RJ; Tsoneva J
Int J Pharm Pract; 2017 Oct; 25(5):351-357. PubMed ID: 27896887
[TBL] [Abstract][Full Text] [Related]
5. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
6. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
7. How do organisational configuration and context influence the quantity and quality of NHS services provided by English community pharmacies? A qualitative investigation.
Jacobs S; Fegan T; Bradley F; Halsall D; Hann M; Schafheutle EI
PLoS One; 2018; 13(9):e0204304. PubMed ID: 30235289
[TBL] [Abstract][Full Text] [Related]
8. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
Wibowo Y; Sunderland B; Hughes J
Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
[TBL] [Abstract][Full Text] [Related]
10. Health champions in South London: evaluation of training, and impact on public health.
Micallef R; Grewal JS; Khan S; Wells J; Kayyali R
Int J Pharm Pract; 2019 Feb; 27(1):71-79. PubMed ID: 29949210
[TBL] [Abstract][Full Text] [Related]
11. Qualitative exploration of the views of healthy living champions from pharmacies in England.
Rutter P; Vryaparj G
Int J Clin Pharm; 2015 Feb; 37(1):27-30. PubMed ID: 25515617
[TBL] [Abstract][Full Text] [Related]
12. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
Wells KM; Thornley T; Boyd MJ; Boardman HF
Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the outcome data supporting the Healthy Living Pharmacy concept and lessons from its implementation.
Nazar ZJ; Nazar H; White S; Rutter P
PLoS One; 2019; 14(3):e0213607. PubMed ID: 30861046
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing pharmacy services in opioid substitution treatment.
Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
[TBL] [Abstract][Full Text] [Related]
16. "It is the future. Clinical pharmaceutical care simply has to be a matter of course." - Community pharmacy clinical service providers' and service developers' views on complex implementation factors.
Weidmann AE; Hoppel M; Deibl S
Res Social Adm Pharm; 2022 Dec; 18(12):4112-4123. PubMed ID: 35987672
[TBL] [Abstract][Full Text] [Related]
17. Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?
Jacobs S; Schafheutle EI; Jee SD; Elvey R; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):166-77. PubMed ID: 23517658
[TBL] [Abstract][Full Text] [Related]
18. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
Lucas B; Blenkinsopp A
Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
[TBL] [Abstract][Full Text] [Related]
19. Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement.
Kinsey H; Scahill S; Bye L; Harrison J
Int J Pharm Pract; 2016 Dec; 24(6):379-389. PubMed ID: 27121985
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
